- Markets
- Healthcare
- SUDARSHAN
SUDARSHAN
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Sudarshan Pharma Industries Says Sachin Mehta Resigns As CFO Effective April 1, 2025
March 6 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
SACHIN MEHTA RESIGNS AS CFO EFFECTIVE APRIL 1, 2025
APPOINTS MANOJ LODHA AS CFO EFFECTIVE APRIL 1, 2025
Source text: ID:nBSE2qmDc2
Further company coverage: SUDA.BO
(([email protected];;))
March 6 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
SACHIN MEHTA RESIGNS AS CFO EFFECTIVE APRIL 1, 2025
APPOINTS MANOJ LODHA AS CFO EFFECTIVE APRIL 1, 2025
Source text: ID:nBSE2qmDc2
Further company coverage: SUDA.BO
(([email protected];;))
Sudarshan Pharma Industries Approves Incorporation Of Unit In Poland
Feb 19 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
BOARD APPROVES INCORPORATION OF UNIT IN POLAND
Source text: ID:nBSE3qC89y
Further company coverage: SUDA.BO
(([email protected];;))
Feb 19 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
BOARD APPROVES INCORPORATION OF UNIT IN POLAND
Source text: ID:nBSE3qC89y
Further company coverage: SUDA.BO
(([email protected];;))
Sudarshan Pharma Industries To Raise 1.88 Billion Rupees Via Preferential Issue
Jan 10 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
SUDARSHAN PHARMA INDUSTRIES - TO RAISE 1.88 BILLION RUPEES VIA PREFERENTIAL ISSUE
SUDARSHAN PHARMA INDUSTRIES - ISSUING 43 MILLION FULLY CONVERTIBLE WARRANTS
Source text: ID:nBSE9hQnsZ
Further company coverage: SUDA.BO
(([email protected];))
Jan 10 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
SUDARSHAN PHARMA INDUSTRIES - TO RAISE 1.88 BILLION RUPEES VIA PREFERENTIAL ISSUE
SUDARSHAN PHARMA INDUSTRIES - ISSUING 43 MILLION FULLY CONVERTIBLE WARRANTS
Source text: ID:nBSE9hQnsZ
Further company coverage: SUDA.BO
(([email protected];))
Sudarshan Pharma Industries To Buy Shares In Sudarshan Pharma Industries For S$10,000
Nov 29 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
SUDARSHAN PHARMA INDUSTRIES- TO BUY SHARES IN SUDARSHAN PHARMA INDUSTRIES PVT FOR S$10,000
Further company coverage: SUDA.BO
(([email protected];))
Nov 29 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
SUDARSHAN PHARMA INDUSTRIES- TO BUY SHARES IN SUDARSHAN PHARMA INDUSTRIES PVT FOR S$10,000
Further company coverage: SUDA.BO
(([email protected];))
Sudarshan Pharma Industries To Acquire 51% Stake Of Ishwari Healthcare
Oct 14 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
TO ACQUIRE 51% STAKE OF ISHWARI HEALTHCARE PVT LTD
DEAL FOR 26 MILLION RUPEES
Source text for Eikon: ID:nBSE2HRLmy
Further company coverage: SUDA.BO
(([email protected];;))
Oct 14 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
TO ACQUIRE 51% STAKE OF ISHWARI HEALTHCARE PVT LTD
DEAL FOR 26 MILLION RUPEES
Source text for Eikon: ID:nBSE2HRLmy
Further company coverage: SUDA.BO
(([email protected];;))
Sudarshan Pharma Industries Approves Sub-Division Of 1 Share Into 10 Shares
Sept 30 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
APPROVED SUB-DIVISION OF 1 SHARE INTO 10 SHARES
Source text for Eikon: ID:nBSEb1CbYl
Further company coverage: SUDA.BO
(([email protected];;))
Sept 30 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
APPROVED SUB-DIVISION OF 1 SHARE INTO 10 SHARES
Source text for Eikon: ID:nBSEb1CbYl
Further company coverage: SUDA.BO
(([email protected];;))
Sudarshan Pharma Industries To Consider Proposal For Sub-Division Of Shares
Sept 24 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
TO CONSIDER PROPOSAL FOR SUB-DIVISION OF SHARES
Source text for Eikon: ID:nBSE9vsbBz
Further company coverage: SUDA.BO
(([email protected];;))
Sept 24 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
TO CONSIDER PROPOSAL FOR SUB-DIVISION OF SHARES
Source text for Eikon: ID:nBSE9vsbBz
Further company coverage: SUDA.BO
(([email protected];;))
Sudarshan Pharma Industries To Consider Raising Of Funds
July 1 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
SUDARSHAN PHARMA INDUSTRIES - TO CONSIDER PROPOSAL FOR RAISING OF FUNDS
Source text for Eikon: ID:nBSE7rkbdd
Further company coverage: SUDA.BO
(([email protected];))
July 1 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
SUDARSHAN PHARMA INDUSTRIES - TO CONSIDER PROPOSAL FOR RAISING OF FUNDS
Source text for Eikon: ID:nBSE7rkbdd
Further company coverage: SUDA.BO
(([email protected];))
Sudarshan Pharma Industries Taking Legal Recourse Against Regan International DMCC
Jan 2 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
SUDARSHAN PHARMA INDUSTRIES LTD - TAKING LEGAL RECOURSE AGAINST REGAN INTERNATIONAL DMCC
SUDARSHAN PHARMA INDUSTRIES LTD - LEGAL RECOURSE FOR NOT IMPORTING CHEMICALS AFTER PAYMENT MADE SIX MONTHS AGO
Source text for Eikon: ID:nBSE96yjJ1
Further company coverage: SUDA.BO
(([email protected];;))
Jan 2 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
SUDARSHAN PHARMA INDUSTRIES LTD - TAKING LEGAL RECOURSE AGAINST REGAN INTERNATIONAL DMCC
SUDARSHAN PHARMA INDUSTRIES LTD - LEGAL RECOURSE FOR NOT IMPORTING CHEMICALS AFTER PAYMENT MADE SIX MONTHS AGO
Source text for Eikon: ID:nBSE96yjJ1
Further company coverage: SUDA.BO
(([email protected];;))
Sudarshan Pharma Industries Names Sachin Mehta As CFO
Dec 12 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
SUDARSHAN PHARMA INDUSTRIES LTD - NAMES SACHIN MEHTA AS CFO
Source text for Eikon: ID:nBSE4Z3pXn
Further company coverage: SUDA.BO
(([email protected];;))
Dec 12 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
SUDARSHAN PHARMA INDUSTRIES LTD - NAMES SACHIN MEHTA AS CFO
Source text for Eikon: ID:nBSE4Z3pXn
Further company coverage: SUDA.BO
(([email protected];;))
Sudarshan Pharma Industries CFO Dharam Jilka Resigns
Sept 15 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
CFO DHARAM JILKA RESIGNS
Source text for Eikon: ID:nBSE7TZks2
Further company coverage: SUDA.BO
(([email protected];;))
Sept 15 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
CFO DHARAM JILKA RESIGNS
Source text for Eikon: ID:nBSE7TZks2
Further company coverage: SUDA.BO
(([email protected];;))
Sudarshan Pharma Industries Says Unit Incorporated In The Name Of Lifescience Chemicals
Aug 24 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
UNIT INCORPORATED IN THE NAME OF LIFESCIENCE CHEMICALS
Source text for Eikon: ID:nBSE2vh4LR
Further company coverage: SUDA.BO
(([email protected];))
Aug 24 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
UNIT INCORPORATED IN THE NAME OF LIFESCIENCE CHEMICALS
Source text for Eikon: ID:nBSE2vh4LR
Further company coverage: SUDA.BO
(([email protected];))
Sudarshan Pharma Industries To Incorporate A Subsidiary Company Named Lifescience Chemicals
Aug 18 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
TO INCORPORATE A SUBSIDIARY COMPANY NAMED LIFESCIENCE CHEMICALS
Source text for Eikon: ID:nBSE4qzlm9
Further company coverage: SUDA.BO
(([email protected];))
Aug 18 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
TO INCORPORATE A SUBSIDIARY COMPANY NAMED LIFESCIENCE CHEMICALS
Source text for Eikon: ID:nBSE4qzlm9
Further company coverage: SUDA.BO
(([email protected];))
Sudarshan Pharma Industries Approves Acquisition Of 100% Stake In Ratna Lifesciences Pvt Ltd
Aug 9 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
APPROVES ACQUISITION OF 100% STAKE IN RATNA LIFESCIENCES PVT LTD
DEAL FOR 55 MILLION RUPEES
ACQUISITION WILL HELP SPIL TO FORAY INTO ONCOLOGY BUSINESS
CO ALSO IN PROCESS TO ACQUIRE ADJACENT MIDC LAND TO INCREASE OVERALL PLANT AREA
LAND ACQUSITION WILL ENABLE RATNA LIFESCIENCES INCREASE ANNUAL TURNOVER ABOUT BY 10 TIMES FROM EXISTING CAPACITY
Source text for Eikon: ID:nBSE43lD3d
Further company coverage: SUDA.BO
(([email protected];))
Aug 9 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
APPROVES ACQUISITION OF 100% STAKE IN RATNA LIFESCIENCES PVT LTD
DEAL FOR 55 MILLION RUPEES
ACQUISITION WILL HELP SPIL TO FORAY INTO ONCOLOGY BUSINESS
CO ALSO IN PROCESS TO ACQUIRE ADJACENT MIDC LAND TO INCREASE OVERALL PLANT AREA
LAND ACQUSITION WILL ENABLE RATNA LIFESCIENCES INCREASE ANNUAL TURNOVER ABOUT BY 10 TIMES FROM EXISTING CAPACITY
Source text for Eikon: ID:nBSE43lD3d
Further company coverage: SUDA.BO
(([email protected];))
Sudarshan Pharma Industries To Consider Acquisition Of Ratna Lifesciences As Unit
July 27 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
TO CONSIDER ACQUISITION OF RATNA LIFESCIENCES AS UNIT
Source text for Eikon: ID:nBSEbm0d8p
Further company coverage: SUDA.BO
(([email protected];))
July 27 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
TO CONSIDER ACQUISITION OF RATNA LIFESCIENCES AS UNIT
Source text for Eikon: ID:nBSEbm0d8p
Further company coverage: SUDA.BO
(([email protected];))
Sudarshan Pharma Industries Re‐Appoints Hemal Mehta As Managing Director
July 21 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
RE‐APPOINTS HEMAL MEHTA AS MANAGING DIRECTOR
RE‐APPOINTS SACHIN MEHTA AS JOINT MANAGING DIRECTOR
Source text for Eikon: ID:nBSE9Qxl8D
Further company coverage: SUDA.BO
(([email protected];))
July 21 (Reuters) - Sudarshan Pharma Industries Ltd SUDA.BO:
RE‐APPOINTS HEMAL MEHTA AS MANAGING DIRECTOR
RE‐APPOINTS SACHIN MEHTA AS JOINT MANAGING DIRECTOR
Source text for Eikon: ID:nBSE9Qxl8D
Further company coverage: SUDA.BO
(([email protected];))
Events:
Split
Dividend
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Sudarshan Pharma Ind do?
Sudarshan Pharma Industries Limited is a company engaged in contract manufacturing and supplying generic pharmaceutical formulations and medicines to healthcare institutions, governments, NGOs, and hospitals through outsourcing and import-export services.
Who are the competitors of Sudarshan Pharma Ind?
Sudarshan Pharma Ind major competitors are Sakar Healthcare, Bharat Parenterals, NGL Fine-Chem, Medicamen Biotech, Kilitch Drugs(India), Shukra Pharma, Fermenta Biotech. Market Cap of Sudarshan Pharma Ind is ₹683 Crs. While the median market cap of its peers are ₹679 Crs.
Is Sudarshan Pharma Ind financially stable compared to its competitors?
Sudarshan Pharma Ind seems to be less financially stable compared to its competitors. Altman Z score of Sudarshan Pharma Ind is 5.01 and is ranked 5 out of its 8 competitors.
Does Sudarshan Pharma Ind pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Sudarshan Pharma Ind latest dividend payout ratio is 10.26% and 3yr average dividend payout ratio is 10.26%
How has Sudarshan Pharma Ind allocated its funds?
Companies resources are allocated to majorly unproductive assets like Accounts Receivable
How strong is Sudarshan Pharma Ind balance sheet?
Balance sheet of Sudarshan Pharma Ind is strong. But short term working capital might become an issue for this company.
Is the profitablity of Sudarshan Pharma Ind improving?
Yes, profit is increasing. The profit of Sudarshan Pharma Ind is ₹12.52 Crs for TTM, ₹11.46 Crs for Mar 2024 and ₹7.04 Crs for Mar 2023.
Is the debt of Sudarshan Pharma Ind increasing or decreasing?
Yes, The debt of Sudarshan Pharma Ind is increasing. Latest debt of Sudarshan Pharma Ind is ₹124 Crs as of Sep-24. This is greater than Mar-24 when it was ₹105 Crs.
Is Sudarshan Pharma Ind stock expensive?
Yes, Sudarshan Pharma Ind is expensive. Latest PE of Sudarshan Pharma Ind is 59.6, while 3 year average PE is 42.13. Also latest EV/EBITDA of Sudarshan Pharma Ind is 20.49 while 3yr average is 17.21.
Has the share price of Sudarshan Pharma Ind grown faster than its competition?
Sudarshan Pharma Ind has given better returns compared to its competitors. Sudarshan Pharma Ind has grown at ~95.99% over the last 2yrs while peers have grown at a median rate of 39.8%
Is the promoter bullish about Sudarshan Pharma Ind?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Sudarshan Pharma Ind is 57.39% and last quarter promoter holding is 57.39%.
Are mutual funds buying/selling Sudarshan Pharma Ind?
There is Insufficient data to gauge this.